Flyer

Journal of Neurology and Neuroscience

  • ISSN: 2171-6625
  • Journal h-index: 18
  • Journal CiteScore: 4.35
  • Journal Impact Factor: 3.75
  • Average acceptance to publication time (5-7 days)
  • Average article processing time (30-45 days) Less than 5 volumes 30 days
    8 - 9 volumes 40 days
    10 and more volumes 45 days
Awards Nomination 20+ Million Readerbase
Indexed In
  • Open J Gate
  • Genamics JournalSeek
  • The Global Impact Factor (GIF)
  • China National Knowledge Infrastructure (CNKI)
  • Directory of Research Journal Indexing (DRJI)
  • OCLC- WorldCat
  • Proquest Summons
  • Scientific Journal Impact Factor (SJIF)
  • Euro Pub
  • Google Scholar
  • Secret Search Engine Labs
Share This Page

Droplet-based digital PCR procedures and optimized NGS to track circulating tumor DNA in liquid biopsies: application to colorectal cancer patient follow-up

Joint Event on 14th International Conference on Neurology, Neuroscience and Neuromuscular Disorders & 31st Edition on World Psychiatrists and Psychologists Conference & 15th International Conference on Gastro Educa
June 17-18, 2019 Tokyo, Japan

Valerie Taly

Paris Descartes University, France

Scientific Tracks Abstracts: J Neurol Neurosci

Abstract:

Tracking of circulating cell-free nucleic acids in body effluents has been greatly facilitated by recent technological developments including droplet-based digital PCR and optimized NGS. In particular, microfluidic droplet based digital PCR has permited to reach unprecedented sensitivity and accuracy for rare cancer biomarker detection. The potential impact of these technologies for cancer patient follow-up will be illustrated by the results obtained from several retrospective and prospective studies.

Biography :

Valerie Taly is a CNRS Research Director and Group Leader of the Translational Research and Microfluidics team within the Clinical Oncology Research unit headed by Prof. P. Laurent- Puig in University Paris Descartes. Her team performs interdisciplinary researches aiming at developing and validating microfluidic tools for cancer research in close collaboration with clinicians and researchers in oncology and toxicology. Since 2008, she developed droplet-based digital procedures for cancer diagnosis. Recently, her research has been dedicated to the clinical validation of droplet-based microfluidics for the non-invasive detection of cancer biomarkers, the highlighting of new cancer biomarkers and the development of original tools and procedures for their detection with applications in personalized medicine, cancer recurrence detection and cancer diagnostics.

E-mail: valerie.taly@parisdescartes.fr